Hospira, Inc. (NYSE: HSP), announced today it has initiated a voluntary recall of 10 lots, identified below, of MitoXANTRONE (both human and veterinary), due to confirmed subpotency and elevated impurity levels.
Company:
Hospira Inc.
Problem
Violation Of Federal Flammability Standard (Recall Alert)